Tower Research Capital (TRC)’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.2K Buy
17,395
+15,678
+913% +$73.2K ﹤0.01% 2553
2025
Q1
$9.2K Sell
1,717
-2,218
-56% -$11.9K ﹤0.01% 3810
2024
Q4
$13.3K Buy
3,935
+264
+7% +$895 ﹤0.01% 3535
2024
Q3
$10.5K Sell
3,671
-21,923
-86% -$62.5K ﹤0.01% 3752
2024
Q2
$57.6K Buy
25,594
+23,438
+1,087% +$52.7K ﹤0.01% 2991
2024
Q1
$4.77K Sell
2,156
-25,692
-92% -$56.8K ﹤0.01% 4632
2023
Q4
$65.4K Buy
27,848
+9,733
+54% +$22.9K ﹤0.01% 2951
2023
Q3
$33.7K Buy
18,115
+13,688
+309% +$25.5K ﹤0.01% 2918
2023
Q2
$11.6K Sell
4,427
-4,534
-51% -$11.9K ﹤0.01% 3936
2023
Q1
$14K Sell
8,961
-9,906
-53% -$15.5K ﹤0.01% 3927
2022
Q4
$25K Sell
18,867
-53,990
-74% -$71.5K ﹤0.01% 2936
2022
Q3
$114K Buy
72,857
+40,913
+128% +$64K ﹤0.01% 2458
2022
Q2
$49K Buy
31,944
+15,465
+94% +$23.7K ﹤0.01% 2910
2022
Q1
$42K Buy
16,479
+7,079
+75% +$18K ﹤0.01% 2877
2021
Q4
$28K Buy
9,400
+3,465
+58% +$10.3K ﹤0.01% 3317
2021
Q3
$15K Buy
5,935
+2,593
+78% +$6.55K ﹤0.01% 4004
2021
Q2
$14K Sell
3,342
-6,222
-65% -$26.1K ﹤0.01% 4195
2021
Q1
$43K Sell
9,564
-5,282
-36% -$23.7K ﹤0.01% 3259
2020
Q4
$73K Sell
14,846
-25,739
-63% -$127K ﹤0.01% 2684
2020
Q3
$241K Buy
40,585
+33,022
+437% +$196K ﹤0.01% 2401
2020
Q2
$20K Buy
7,563
+5,423
+253% +$14.3K ﹤0.01% 3689
2020
Q1
$4K Sell
2,140
-5,653
-73% -$10.6K ﹤0.01% 2408
2019
Q4
$55K Buy
7,793
+7,267
+1,382% +$51.3K ﹤0.01% 1283
2019
Q3
$5K Sell
526
-3,145
-86% -$29.9K ﹤0.01% 3347
2019
Q2
$42K Buy
+3,671
New +$42K ﹤0.01% 1712
2019
Q1
Sell
-1,016
Closed -$17K 4341
2018
Q4
$17K Sell
1,016
-3,072
-75% -$51.4K ﹤0.01% 2073
2018
Q3
$72K Buy
+4,088
New +$72K 0.01% 1543